AJP - Lung Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 287: L970-L980, 2004. First published July 2, 2004; doi:10.1152/ajplung.00398.2003
1040-0605/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/5/L970    most recent
00398.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kolosova, I. A.
Right arrow Articles by Verin, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kolosova, I. A.
Right arrow Articles by Verin, A. D.

Role of CPI-17 in the regulation of endothelial cytoskeleton

Irina A. Kolosova,1 Shwu-Fan Ma,1 Djanybek M. Adyshev,1 Peyi Wang,1 Motoi Ohba,2 Viswanathan Natarajan,1 Joe G. N. Garcia,1 and Alexander D. Verin1

1Department of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224; and 2Institute of Molecular Oncology, Showa University, Tokyo, Japan

Submitted 19 November 2003 ; accepted in final form 25 June 2004

We have previously shown that myosin light chain (MLC) phosphatase (MLCP) is critically involved in the regulation of agonist-mediated endothelial permeability and cytoskeletal organization (Verin AD, Patterson CE, Day MA, and Garcia JG. Am J Physiol Lung Cell Mol Physiol 269: L99–L108, 1995). The molecular mechanisms of endothelial MLCP regulation, however, are not completely understood. In this study we found that, similar to smooth muscle, lung microvascular endothelial cells expressed specific endogenous inhibitor of MLCP, CPI-17. To elucidate the role of CPI-17 in the regulation of endothelial cytoskeleton, full-length CPI-17 plasmid was transiently transfected into pulmonary artery endothelial cells, where the background of endogenous protein is low. CPI-17 had no effect on cytoskeleton under nonstimulating conditions. However, stimulation of transfected cells with direct PKC activator PMA caused a dramatic increase in F-actin stress fibers, focal adhesions, and MLC phosphorylation compared with untransfected cells. Inflammatory agonist histamine and, to a much lesser extent, thrombin were capable of activating CPI-17. Histamine caused stronger CPI-17 phosphorylation than thrombin. Inhibitory analysis revealed that PKC more significantly contributes to agonist-induced CPI-17 phosphorylation than Rho-kinase. Dominant-negative PKC-{alpha} abolished the effect of CPI-17 on actin cytoskeleton, suggesting that the PKC-{alpha} isoform is most likely responsible for CPI-17 activation in the endothelium. Depletion of endogenous CPI-17 in lung microvascular endothelial cell significantly attenuated histamine-induced increase in endothelial permeability. Together these data suggest the potential importance of PKC/CPI-17-mediated pathway in histamine-triggered cytoskeletal rearrangements leading to lung microvascular barrier compromise.

myosin phosphatase; myosin light chain phosphorylation; endothelial barrier


Address for reprint requests and other correspondence: A. D. Verin, 5200 Eastern Ave., Center Tower, MFL Bldg., 6th Fl., Baltimore, MD 21224 (E-mail: averin1{at}jhmi.edu)




This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Csortos, I. Czikora, N. V. Bogatcheva, D. M. Adyshev, C. Poirier, G. Olah, and A. D. Verin
TIMAP is a positive regulator of pulmonary endothelial barrier function
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L440 - L450.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Csortos, I. Kolosova, and A. D. Verin
Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L843 - L854.
[Abstract] [Full Text] [PDF]

Home page
 GENES CELLSHome page
A. Maeda, Y.-i. Ozaki, S. Sivakumaran, T. Akiyama, H. Urakubo, A. Usami, M. Sato, K. Kaibuchi, and S. Kuroda
Ca-independent phospholipase A2-dependent sustained Rho-kinase activation exhibits all-or-none response.
Genes Cells, September 1, 2006; 11(9): 1071 - 1083.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Holinstat, N. Knezevic, M. Broman, A. M. Samarel, A. B. Malik, and D. Mehta
Suppression of RhoA Activity by Focal Adhesion Kinase-induced Activation of p190RhoGAP: ROLE IN REGULATION OF ENDOTHELIAL PERMEABILITY
J. Biol. Chem., January 27, 2006; 281(4): 2296 - 2305.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.